Bufferin
About Bufferin
Bufferin was established in 1996 as a manufacturer within the consumer health products sector. Operations focus on the production of hand sanitizers and aspirin formulations for everyday use. The companys activities center on formulation and distribution through its domain, bufferin.com, without specified geographic headquarters. Standard quality controls are applied to ensure product reliability in the pharmaceutical and hygiene markets.
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Genomma Lab
(Jun 14, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bufferin
Detailed funding history for Bufferin
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bufferin
Bufferin has secured backing from 1 investor. Prominent investors backing the company include Genomma Lab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
OTC and generic drugs are manufactured and distributed.
|
Locked | Locked | Locked |
Investor details for Bufferin
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bufferin
Investment portfolio details for Bufferin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bufferin
Detailed financials for Bufferin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bufferin Comparisons
Peer comparison for Bufferin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bufferin
Detailed competitors of Bufferin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bufferin
Complete news archive for Bufferin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bufferin
Bufferin was founded in 1996.
Bufferin was established in 1996 as a manufacturer within the consumer health products sector. Operations focus on the production of hand sanitizers and aspirin formulations for everyday use. The companys activities center on formulation and distribution through its domain, bufferin.com, without specified geographic headquarters. Standard quality controls are applied to ensure product reliability in the pharmaceutical and hygiene markets.
Bufferin has 1 investor. Key investors include Genomma Lab.